Streetbeat News

Regulatory

COYA

Coya Therapeutics (NASDAQ:COYA) has successfully engineered regulatory T cell derived exosomes with CTLA-4 protein to selectively target immune cells. This technology could potentially deliver targeted therapies across multiple diseases. The technology requires no genetic modifications and overcomes known limitations of exosome manipulation. The company's proprietary technology expands its pipeline to include autoimmune disorders and cancer.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 1:26 pm

ONDS

Airobotics, a company owned by Ondas Holdings (NASDAQ:ONDS), has become the first US company to receive the FAA's Airworthiness Certification for a Drone-In-A-Box. The Optimus-1EX Uncrewed Aircraft was granted a Type Certificate, allowing it to operate in complex urban environments. The certification was achieved after four years of intensive engineering and operational review processes. The Optimus System is already operating in the United Arab Emirates and Airobotics plans to conduct similar operations in urban environments across the U.S.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 1:23 pm

NUE

PKX

RS

SLX

X

The US and EU are negotiating a partnership to counter China's steel surplus, potentially introducing tariffs targeting imports from China. This is part of the broader Global Arrangement on Sustainable Steel and Aluminum, which aims to settle a dispute that began when former President Trump imposed tariffs on metal imports from Europe. The VanEck Steel ETF (NYSE:SLX), which includes various sectors such as materials, metals, and mining, has shown a 35% return over the past year. Notable US steel producers include POSCO Holdings Inc. (NYSE:PKX), U.S. Steel Corp. (NYSE:X), Nucor Corp. (NYSE:NUE), and Reliance Steel & Aluminum Co. (NYSE:RS).

Portfolio Pulse from Piero Cingari

September 07, 2023 | 1:20 pm

HRMY

Harmony Biosciences has been granted Orphan Drug designation for Pitolisant, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:13 pm

ELOX

Eloxx Pharmaceuticals has submitted an Investigational New Drug (IND) application to the U.S. FDA for ELX-02 for the treatment of Alport syndrome. All 3 Alport patients treated with ELX-02 had disease regression, suggesting clinical benefit with longer treatment duration. There is significant strategic interest in ZKN-013 following FDA approval to start Phase 1 trial.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:03 pm

AAPL

Apple Inc's shares are trading lower due to reports of China expanding its ban on the use of iPhones to government-backed agencies and state companies.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 12:54 pm

AAPL

NVDA

China is broadening its ban on iPhones in sensitive departments, including government-backed agencies and state companies, signaling increasing difficulties for Apple Inc (AAPL) in its largest foreign market. This move is part of Beijing's efforts to reduce reliance on American technology. The ban threatens Apple's position in a market responsible for about a fifth of its revenue. Other U.S. companies with significant exposure to China, including Nvidia Corp (NVDA), are also concerned about China's next move.

Portfolio Pulse from Anusuya Lahiri

September 07, 2023 | 12:53 pm

CNSP

CNS Pharmaceuticals has reached a milestone with the enrollment of 200 patients in its potentially pivotal study of Berubicin for the treatment of Glioblastoma Multiforme. The completion of enrollment for the study is on track by the end of 2023, with topline data results from interim analysis also expected to be announced by the end of 2023.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 12:48 pm

SKYX

SKYX Platforms Corp. (NASDAQ:SKYX) has announced the issuance of three new patents in the U.S., Europe, and Japan for its all-in-one smart modular platform technology for ceilings in homes and buildings. This brings the company's intellectual property portfolio to a total of 72 issued and pending patents, 18 of which are issued patents covering SKYX's advanced and smart technologies.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 12:47 pm

SPY

The USA Nonfarm Productivity for Q2 has been reported at 3.5%, slightly below the estimated 3.7%, but significantly higher than the previous quarter's -2.1%.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 12:30 pm